Stockholders Deficit (Details) - USD ($)				1 Months Ended								2 Months Ended	3 Months Ended			9 Months Ended
	Apr. 08, 2020	Jan. 15, 2020	Jan. 13, 2020	Aug. 31, 2020	Apr. 29, 2020	Apr. 23, 2020	Feb. 19, 2020	Jan. 30, 2020	Jan. 24, 2020	Jan. 23, 2020	Jan. 22, 2020	Sep. 24, 2020	Jun. 30, 2020	Mar. 31, 2020	Mar. 31, 2019	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Stockholders Deficit (Details) [Line Items]
Common stock value (in Dollars)													$ 531,100	$ 1,113,000	$ 150,000
Agreement Description																We have entered into a Mutual Release and Hold Harmless Agreement with a stockholder resolving claims related to the issuance of 1,000,000 shares of our common stock, par value $0.001 per share, to that stockholder, as directed by prior company CEO George Farley, as compensation for valuation services.
Grant date price (in Dollars per share)																		$ 0.34
Loan agreement, description																The notes mature September 1, 2019. The notes are accompanied by a Common Stock Purchase Warrant entitling the holder to purchase one share of the company’s common stock, par value $0.001 per share, for each $2.00 of Note principle, at an exercise price of $0.07 per share, for two years from the date of issuance.
Beneficial conversion feature (in Dollars)																$ 708,000
Par value (in Dollars per share)																$ 0.001	$ 0.001
Shares authorized																2,000,000	2,000,000
Shares issued																13,602	13,602
Shares outstanding																13,602	13,602
Description of stock-based compensation																The $344,000 stock-based compensation for the quarter ended September 30, 2020 was comprised of $177,000 option expense and $167,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of Applied Optical Sciences as well as the recognition of $3,000 for the restricted stock agreements.
Option exercise [Member]
Stockholders Deficit (Details) [Line Items]
Common stock value (in Dollars)	$ 63,000
Common stock shares	900,000
Common stock [Member]
Stockholders Deficit (Details) [Line Items]
Common stock value (in Dollars)			$ 45,000				$ 510,000		$ 60,000	$ 204,000	$ 204,000		$ 1,770	$ 3,710	$ 2,500
Common stock shares			150,000				1,700,000		200,000	680,000	680,000		1,770,334	3,710,000	2,500,000
Common stock [Member] | Two Individual [Member]
Stockholders Deficit (Details) [Line Items]
Common stock value (in Dollars)		$ 30,000	$ 60,000
Common stock shares		100,000	200,000
Warrant [Member]
Stockholders Deficit (Details) [Line Items]
Common stock value (in Dollars)	$ 11,000							$ 1,750
Common stock shares	150,000							25,000
Subscription Agreements [Member]
Stockholders Deficit (Details) [Line Items]
Common stock value (in Dollars)	$ 60,000
Common stock shares	200,000
Promissory Notes [Member]
Stockholders Deficit (Details) [Line Items]
Loan agreement, description																During the quarter ended September 30, 2020, we received $4,324,000 in bridge funding pursuant to 10% Convertible Promissory Notes. Also, during the quarter, notes containing a principal balance of $410,000 with a maturity date of September 1, 2019 and a principal balance of $620,000 with a maturity date of December 1, 2019 were exchanged into this portfolio of notes payable. These notes are convertible into shares of our common stock at a conversion price of $0.30 per share, as negotiated with the holders based on the prevailing market price of the common stock leading up to the issuance of the notes. At any time after October 15, 2020 until July 15, 2021, the date of maturity, (i) each investor may elect to convert these notes into shares of our common stock, at a conversion price of $0.30 per share and (ii) the company may elect to prepay, either in cash or in shares of common stock at a price of $0.30 per share, at the option of the holder, the amount of principal and interest then outstanding under each note. In the event we elect to prepay the notes, we will notify the holders, each of whom will then have five business days to notify the company if they prefer to receive such prepayment in cash or stock. These notes are payable in full at maturity. In lieu of repayment of the principal and interest on the notes at maturity, the Company may elect to convert the amounts due into shares of Common Stock at a price of $0.15 per share.
Stephen W McCahon [Membe]
Stockholders Deficit (Details) [Line Items]
Share of common stock repurchased				5,000,000
Common stock repurchased (in Dollars)				$ 300,000
Mr. Farley’s attorney
Stockholders Deficit (Details) [Line Items]
Advance amount (in Dollars)												$ 1,000,000
Common stock [Member]
Stockholders Deficit (Details) [Line Items]
Common stock value (in Dollars)					$ 400,000	$ 71,000
Common stock shares					1,333,333	237,000
Common stock [Member] | Restricted stock [Member]
Stockholders Deficit (Details) [Line Items]
Shares of common stock					18,750
Grant date price (in Dollars per share)													$ 0.35
Convertible Preferred Stock [Member]
Stockholders Deficit (Details) [Line Items]
Par value (in Dollars per share)																$ 0.001
Shares authorized																2,000,000
Shares issued																13,602	13,602
Shares outstanding																13,602